Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (24), 3791-3795
- https://doi.org/10.1016/0006-2952(83)90151-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The in vitro teratogenicity of cyclophosphamide in rat embryosTeratology, 1982
- Teratogenicity of cyclophosphamide metabolites: Phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitroToxicology and Applied Pharmacology, 1981
- Investigations on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantationTeratology, 1981
- Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture systemToxicology, 1981
- Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture systemBiochemical Pharmacology, 1981
- Cyclophosphamide cystitis—Identification of acrolein as the causative agentBiochemical Pharmacology, 1979
- Teratogenic bioactivation of cyclophosphamideLife Sciences, 1979
- In vitro metabolism of cyclophosphamide in limb bud cultureTeratology, 1979
- The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorinesZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideBiochemical Pharmacology, 1974